Takeda hires compliance officer
Takeda Pharmaceuticals has hired Jeanine Jiganti as the company's chief compliance officer. Jiganti, formerly with the Illinois Department of Commerce and Economic Opportunity, will advise senior management on compliance and regulatory issues and promote compliance with applicable laws and company policies. Takeda's joint venture with Abbott, TAP, reached a settlement with federal prosecutors in 2001 to resolve allegations of violations of the Prescription Drugs Marketing Act and the False Claims Act (1"The Pink Sheet" July 19, 2004, p. 14)...
You may also be interested in...
The acquittal of eight current and former TAP employees on conspiracy charges suggests that the perception of shifting standards for marketing compliance will make it difficult for prosecutors to translate corporate settlements into convictions of individual executives
Data presented at AAAI meeting show reduced annualized asthma exacerbation rates across all patient populations, but doctors are unlikely to switch patients served well by existing biologics.
The RNA drug’s accelerated approval brings Sarepta’s exon-skipping market share to nearly 30%.